JP2009543800A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009543800A5 JP2009543800A5 JP2009519633A JP2009519633A JP2009543800A5 JP 2009543800 A5 JP2009543800 A5 JP 2009543800A5 JP 2009519633 A JP2009519633 A JP 2009519633A JP 2009519633 A JP2009519633 A JP 2009519633A JP 2009543800 A5 JP2009543800 A5 JP 2009543800A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- seq
- individual
- pharmaceutical composition
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 231100000241 scar Toxicity 0.000 claims description 15
- 208000032544 Cicatrix Diseases 0.000 claims description 14
- 230000037387 scars Effects 0.000 claims description 14
- 208000002260 Keloid Diseases 0.000 claims description 9
- 230000001969 hypertrophic effect Effects 0.000 claims description 9
- 210000001117 keloid Anatomy 0.000 claims description 9
- 230000019612 pigmentation Effects 0.000 claims description 2
- 229920001184 polypeptide Polymers 0.000 claims 14
- 102000004196 processed proteins & peptides Human genes 0.000 claims 14
- 108090000765 processed proteins & peptides Proteins 0.000 claims 14
- 239000008194 pharmaceutical composition Substances 0.000 claims 8
- 201000010099 disease Diseases 0.000 claims 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 6
- 239000003814 drug Substances 0.000 claims 6
- 230000003176 fibrotic effect Effects 0.000 claims 5
- 210000004899 c-terminal region Anatomy 0.000 claims 4
- 238000004519 manufacturing process Methods 0.000 claims 4
- 230000002401 inhibitory effect Effects 0.000 claims 3
- 230000001629 suppression Effects 0.000 claims 3
- 206010000050 Abdominal adhesions Diseases 0.000 claims 2
- 206010007559 Cardiac failure congestive Diseases 0.000 claims 2
- 208000007342 Diabetic Nephropathies Diseases 0.000 claims 2
- 206010012689 Diabetic retinopathy Diseases 0.000 claims 2
- 206010016654 Fibrosis Diseases 0.000 claims 2
- 206010019280 Heart failures Diseases 0.000 claims 2
- 208000010159 IgA glomerulonephritis Diseases 0.000 claims 2
- 206010021263 IgA nephropathy Diseases 0.000 claims 2
- 206010039710 Scleroderma Diseases 0.000 claims 2
- 210000000941 bile Anatomy 0.000 claims 2
- 230000007882 cirrhosis Effects 0.000 claims 2
- 208000019425 cirrhosis of liver Diseases 0.000 claims 2
- 208000033679 diabetic kidney disease Diseases 0.000 claims 2
- 206010061989 glomerulosclerosis Diseases 0.000 claims 2
- 208000002780 macular degeneration Diseases 0.000 claims 2
- 125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 claims 2
- 229940079593 drug Drugs 0.000 claims 1
- 239000000835 fiber Substances 0.000 claims 1
- 208000015891 sexual disease Diseases 0.000 claims 1
- 230000002463 transducing effect Effects 0.000 claims 1
- 230000026683 transduction Effects 0.000 claims 1
- 238000010361 transduction Methods 0.000 claims 1
- 238000000034 method Methods 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US83027906P | 2006-07-12 | 2006-07-12 | |
| US60/830,279 | 2006-07-12 | ||
| US84904106P | 2006-10-02 | 2006-10-02 | |
| US60/849,041 | 2006-10-02 | ||
| PCT/US2007/073144 WO2008008772A2 (en) | 2006-07-12 | 2007-07-10 | Methods for treating and limiting fibrotic disorders and keloids |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009543800A JP2009543800A (ja) | 2009-12-10 |
| JP2009543800A5 true JP2009543800A5 (https=) | 2012-07-19 |
| JP5048772B2 JP5048772B2 (ja) | 2012-10-17 |
Family
ID=38924094
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009519633A Expired - Fee Related JP5048772B2 (ja) | 2006-07-12 | 2007-07-10 | 線維性疾患及びケロイドを治療及び抑制する方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20110028398A1 (https=) |
| EP (1) | EP2051727A4 (https=) |
| JP (1) | JP5048772B2 (https=) |
| KR (1) | KR101267217B1 (https=) |
| AU (1) | AU2007272578B2 (https=) |
| BR (1) | BRPI0714383A2 (https=) |
| CA (1) | CA2657263A1 (https=) |
| CR (1) | CR10552A (https=) |
| DO (1) | DOP2009000005A (https=) |
| MX (1) | MX2009000359A (https=) |
| NZ (1) | NZ574717A (https=) |
| SG (1) | SG173369A1 (https=) |
| WO (1) | WO2008008772A2 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2007342674B2 (en) | 2007-01-10 | 2013-09-19 | Purdue Research Foundation | Polypeptide inhibitors of HSP27 kinase and uses therefor |
| JP5703466B2 (ja) | 2007-08-07 | 2015-04-22 | パーデュー・リサーチ・ファウンデーションＰｕｒｄｕｅ Ｒｅｓｅａｒｃｈ Ｆｏｕｎｄａｔｉｏｎ | キナーゼ阻害薬およびその使用 |
| WO2010027831A1 (en) * | 2008-08-25 | 2010-03-11 | Excaliard Pharmaceuticals, Inc. | Method for reducing scarring during wound healing using antisense compounds directed to ctgf |
| CA2744104C (en) | 2008-12-10 | 2017-07-18 | Purdue Research Foundation | Cell-permeant peptide-based inhibitor of kinases |
| US9890195B2 (en) | 2009-07-27 | 2018-02-13 | Purdue Research Foundation | MK2 inhibitor compositions and methods to enhance neurite outgrowth, neuroprotection, and nerve regeneration |
| WO2013134177A1 (en) * | 2012-03-05 | 2013-09-12 | Capstone Therapeutics Corp. | Methods and compositions for improving spinal surgery outcomes |
| WO2013134636A1 (en) | 2012-03-09 | 2013-09-12 | Purdue Research Foundation | Compositions and methods for delivery of kinase inhibiting peptides |
| KR102166543B1 (ko) * | 2014-06-02 | 2020-10-16 | 주식회사 젬백스앤카엘 | 켈로이드 억제용 조성물 및 그 억제 방법 |
| EP3172240A4 (en) * | 2014-07-22 | 2018-04-18 | The Regents of the University of California | Endosomal escape domains for delivery of macromolecules into cells |
| KR101667900B1 (ko) * | 2016-01-15 | 2016-10-21 | 테고사이언스 (주) | 켈로이드성 피부 또는 켈로이드 흉터 진단용 바이오마커 단백질 및 이의 이용 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5280038A (en) * | 1992-03-13 | 1994-01-18 | Virginia Commonwealth University | Histidine as a protective agent in cardiac surgery and myocardial ischemic syndrome |
| US5985635A (en) * | 1996-11-15 | 1999-11-16 | Incyte Pharmaceuticals, Inc. | Nucleic acids encoding novel human serine/threonine protein kinases |
| US7556722B2 (en) * | 1996-11-22 | 2009-07-07 | Metzger Hubert F | Electroplating apparatus |
| US6475490B1 (en) * | 1998-10-19 | 2002-11-05 | Fordham University | Compositions and methods for promoting tissue repair using heat shock proteins |
| US6812205B2 (en) * | 2000-03-15 | 2004-11-02 | The Brigham & Women's Hospital, Inc. | Suppression of vascular disorders by mucosal administration of heat shock protein peptides |
| JP2005506836A (ja) * | 2001-08-23 | 2005-03-10 | アリゾナ・ボード・オブ・リージェンツ | 平滑筋治療用薬剤および方法 |
| US20030190364A1 (en) * | 2002-04-01 | 2003-10-09 | Alyssa Panitch | Biological affinity based delivery systems |
| DE602004001509T2 (de) * | 2003-02-21 | 2007-02-15 | Arizona Board Of Regents, Tempe | Verwendung von hsp20 zur förderung der wundheilung und / oder zur reduzierung von narbenbildung |
| AU2004281838B2 (en) * | 2003-10-17 | 2008-01-31 | Arizona Board Of Regents | Novel heat shock protein 20-related polypeptides and uses therefor |
| JP2009033589A (ja) * | 2007-07-30 | 2009-02-12 | Ricoh Co Ltd | 画像形成装置、プログラムおよび記録媒体 |
-
2007
- 2007-07-10 EP EP07799441A patent/EP2051727A4/en not_active Withdrawn
- 2007-07-10 AU AU2007272578A patent/AU2007272578B2/en not_active Ceased
- 2007-07-10 SG SG2011050457A patent/SG173369A1/en unknown
- 2007-07-10 US US12/305,885 patent/US20110028398A1/en not_active Abandoned
- 2007-07-10 NZ NZ574717A patent/NZ574717A/en not_active IP Right Cessation
- 2007-07-10 JP JP2009519633A patent/JP5048772B2/ja not_active Expired - Fee Related
- 2007-07-10 WO PCT/US2007/073144 patent/WO2008008772A2/en not_active Ceased
- 2007-07-10 KR KR1020097000515A patent/KR101267217B1/ko not_active Expired - Fee Related
- 2007-07-10 MX MX2009000359A patent/MX2009000359A/es active IP Right Grant
- 2007-07-10 BR BRPI0714383-4A patent/BRPI0714383A2/pt not_active IP Right Cessation
- 2007-07-10 CA CA002657263A patent/CA2657263A1/en not_active Abandoned
-
2009
- 2009-01-09 DO DO2009000005A patent/DOP2009000005A/es unknown
- 2009-01-09 CR CR10552A patent/CR10552A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009543800A5 (https=) | ||
| Boulon et al. | Characterization of the antiviral effects of REP 2139 on the HBV lifecycle in vitro | |
| MX2026002524A (es) | Compuestos agonistas de gipr | |
| JP2013516427A5 (https=) | ||
| RU2015132208A (ru) | Модуляция экспрессии гентингтина | |
| MA32539B1 (fr) | Traitement du diabète chez des patients pour lesquels une thérapie par la metformine n'est pas appropriée | |
| KR20180118259A (ko) | 표적 세포 내에서 치료적 단백질의 표적화된 생산을 위한 시스템 및 방법 | |
| JP2006520611A5 (https=) | ||
| CA2730789A1 (en) | Treatment of inflammatory bowel diseases with mammal beta defensins | |
| JPWO2019156137A5 (https=) | ||
| JP2016505612A5 (https=) | ||
| JP2012505154A5 (https=) | ||
| ATE522215T1 (de) | Verwendung von 3,11b-cis-dihydrotetrabenazine zur behandlung von symptomen von huntington-chorea | |
| Kopp et al. | Type 2 diabetes mellitus/obesity drugs: A neurodegenerative disorders savior or a bridge too far? | |
| WO2007096396A3 (en) | Methods for treating autoimmune or demyelinating diseases | |
| JP2016516054A5 (https=) | ||
| Banik et al. | A novel bioavailable curcumin-galactomannan complex modulates the genes responsible for the development of chronic diseases in mice: A RNA sequence analysis | |
| Fan et al. | Neurotrophic factor-α1/carboxypeptidase E controls progression and reversal of Alzheimer's disease pathogenesis in mice | |
| WO2011060534A8 (en) | Trim5alpha mutants and uses thereof | |
| WO2010086867A3 (en) | Peptides, pharmaceutical compositions comprising same and uses thereof | |
| Shi et al. | Local application of MDL28170-loaded PCL film improves functional recovery by preserving survival of motor neurons after traumatic spinal cord injury | |
| WO2016033432A9 (en) | Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition | |
| CN106222173B (zh) | circRNA MNCR在调节心肌细胞坏死和心肌缺血损伤中的作用 | |
| EA200700772A1 (ru) | Аналоги полиаминов в качестве терапевтических средств для глазных заболеваний | |
| JP2017524727A5 (https=) |